FR2440371A1 - Nouveaux composes azotes heterocycliques, des compositions pharmaceutiques en contenant et des procedes pour les preparer - Google Patents

Nouveaux composes azotes heterocycliques, des compositions pharmaceutiques en contenant et des procedes pour les preparer

Info

Publication number
FR2440371A1
FR2440371A1 FR7926530A FR7926530A FR2440371A1 FR 2440371 A1 FR2440371 A1 FR 2440371A1 FR 7926530 A FR7926530 A FR 7926530A FR 7926530 A FR7926530 A FR 7926530A FR 2440371 A1 FR2440371 A1 FR 2440371A1
Authority
FR
France
Prior art keywords
same
pharmaceutical compositions
preparing
methods
compositions containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7926530A
Other languages
English (en)
Other versions
FR2440371B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fisons Ltd
Original Assignee
Fisons Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fisons Ltd filed Critical Fisons Ltd
Publication of FR2440371A1 publication Critical patent/FR2440371A1/fr
Application granted granted Critical
Publication of FR2440371B1 publication Critical patent/FR2440371B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88—Oxygen atoms
    • C07D239/90—Oxygen atoms with acyclic radicals attached in position 2 or 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/24—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D335/06—Benzothiopyrans; Hydrogenated benzothiopyrans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Abstract

L'INVENTION CONCERNE L'INDUSTRIE PHARMACEUTIQUE. ELLE A POUR OBJET DES COMPOSES HETEROCYCLIQUES AZOTES TELS QUE L'ACIDE 6-CHLORO-4-OXO-10-PROPYL-4H-PYRANNO3,2-GQUINOLEINE-2,8-DICARBOXYLIQUE; L'ACIDE 6-METHOXY-4-OXO-10-PROPYL-4H-PYRANNO3,2-GQUINOLEINE-2,8-DICARBOXYLIQUE, EVENTUELLEMENT SOUS FORME SALIFIEE. CES COMPOSES SONT PREFERES POUR LA PREPARATION DE COMPOSITIONS PHARMACEUTIQUES CONVENANT POUR LE TRAITEMENT D'AFFECTIONS AYANT UNE COMPOSANTE ALLERGIQUE.
FR7926530A 1978-10-31 1979-10-25 Nouveaux composes azotes heterocycliques, des compositions pharmaceutiques en contenant et des procedes pour les preparer Granted FR2440371A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB7842679 1978-10-31
GB7920760 1979-06-14

Publications (2)

Publication Number Publication Date
FR2440371A1 true FR2440371A1 (fr) 1980-05-30
FR2440371B1 FR2440371B1 (fr) 1983-01-28

Family

ID=26269406

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7926530A Granted FR2440371A1 (fr) 1978-10-31 1979-10-25 Nouveaux composes azotes heterocycliques, des compositions pharmaceutiques en contenant et des procedes pour les preparer

Country Status (32)

Country Link
US (1) US4419352A (fr)
AR (1) AR230449A1 (fr)
AT (1) AT379811B (fr)
AU (1) AU528648B2 (fr)
BR (1) BR7907006A (fr)
CA (1) CA1142520A (fr)
CH (1) CH643264A5 (fr)
CS (1) CS231166B2 (fr)
CU (1) CU21123A (fr)
DD (1) DD146954A5 (fr)
DE (1) DE2943658A1 (fr)
DK (1) DK458679A (fr)
FI (1) FI67702C (fr)
FR (1) FR2440371A1 (fr)
GR (1) GR73861B (fr)
HK (1) HK66185A (fr)
HU (1) HU183087B (fr)
IE (1) IE49464B1 (fr)
IL (1) IL58579A (fr)
KE (1) KE3540A (fr)
LU (1) LU81841A1 (fr)
MA (1) MA18631A1 (fr)
MY (1) MY8500439A (fr)
NL (1) NL7907916A (fr)
NO (1) NO154522C (fr)
NZ (1) NZ191956A (fr)
PH (1) PH15442A (fr)
PL (1) PL130691B1 (fr)
PT (1) PT70392A (fr)
SE (1) SE451071B (fr)
SG (1) SG40885G (fr)
SU (1) SU1014476A3 (fr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260306A (en) * 1981-07-24 1993-11-09 Fisons Plc Inhalation pharmaceuticals
GB8402047D0 (en) * 1984-01-26 1984-02-29 Fisons Plc Nitrogen heterocycles
DE3584580D1 (de) * 1984-04-13 1991-12-12 Fisons Plc Formen und formulierungen des nedocromil-natriumsalzes.
GB8501015D0 (en) * 1985-01-16 1985-02-20 Riker Laboratories Inc Drug
GB8607159D0 (en) * 1986-03-22 1986-04-30 Smith & Nephew Ass Pharmaceutical composition
HU202753B (en) * 1986-06-21 1991-04-29 Sandoz Ag Process for producing retard pharmaceutical compositions containing cetotiphene
USRE38628E1 (en) * 1986-12-23 2004-10-19 Fisons Plc Pharmaceutical compositions
DE3787274T2 (de) * 1986-12-23 1994-01-27 Fisons Plc Pharmazeutische Präparate, die eine wässerige Lösung eines Pyranoquinolins enthalten.
USH672H (en) 1986-12-31 1989-09-05 E. R. Squibb & Sons, Inc. Stable antifungal capsule formulation
US4767612A (en) * 1987-01-23 1988-08-30 Rorer Pharmaceutical Corporation Triamcinolone acetonide for the treatment of allergic rhinitis
GB8704089D0 (en) * 1987-02-21 1987-03-25 Fisons Plc Method of treatment
GB2202145B (en) * 1987-03-17 1991-01-02 Fisons Plc Compositions of nedocromil for dermatological use.
US5648084A (en) * 1990-02-28 1997-07-15 Guttag; Alvin Multiple dosage medicine drop bottle
AU650036B2 (en) * 1990-07-25 1994-06-09 Teijin Limited Benzopyran derivative, production thereof, and pharmaceutical composition containing the same
US5294433A (en) * 1992-04-15 1994-03-15 The Procter & Gamble Company Use of H-2 antagonists for treatment of gingivitis
US5453431A (en) * 1993-10-29 1995-09-26 Gilman; Andrew L. Use of hydroxychloroquine for treatment of graft-versus-host disease
ZA966579B (en) * 1995-08-04 1998-02-02 Wakamoto Pharma Co Ltd O/W emulsion composition for eye drops.
US5891472A (en) * 1996-11-19 1999-04-06 Meri Charmyne Russell Treatment of equine laminitis
US5989571A (en) * 1997-07-23 1999-11-23 Millenium Pharmaceutical Technologies, Inc. Contact dermatitis pharmaceutical preparation with anti-histamine and anti-inflammatory
US5885550A (en) * 1998-07-02 1999-03-23 Vallier; Deandra K. Ophthalmic whitening solution
US7101547B1 (en) 1999-01-22 2006-09-05 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Method for the prevention and treatment of diseases caused by an inflammatory response mediated by endogenous substance P by using anti-substance P antibodies
AU2001264616A1 (en) * 2000-05-17 2001-11-26 Cor Therapeutics, Inc. Methods for producing amino substituted chromanes and intermediates therefor
US9132116B2 (en) 2004-08-02 2015-09-15 Willowcroft Pharm Inc. Mast cell stabilizers to prevent or treat laminitis
GB0524808D0 (en) * 2005-12-05 2006-01-11 Novartis Ag Organic compounds
DE102007028095A1 (de) * 2007-06-19 2009-01-15 Bachmann, Vincent Zubereitung zur Behandlung von Hufrehe bei Equiden
FR2924344B1 (fr) * 2007-12-04 2010-04-16 Pf Medicament Utilisation de la mequitazine sous la forme de racemate ou d'enantiomeres pour la preparation d'un medicament destine au traitement ou a la prevention de pathologies impliquant les recepteurs histaminiques h4.
EP2424527B8 (fr) * 2009-04-29 2019-07-17 Willowcraft Pharm Inc. Stabilisateurs de mastocytes utilisés pour prévenir ou traiter la fourbure

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1504709A (en) * 1974-12-07 1978-03-22 Fisons Ltd N-substituted quinolinone-2-carboxyl. acid der
FR2389627A1 (fr) * 1977-05-04 1978-12-01 Fisons Ltd

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4143042A (en) * 1977-03-08 1979-03-06 Takeda Chemical Industries, Ltd. 1-azaxanthone-3-carboxylic acids

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1504709A (en) * 1974-12-07 1978-03-22 Fisons Ltd N-substituted quinolinone-2-carboxyl. acid der
FR2389627A1 (fr) * 1977-05-04 1978-12-01 Fisons Ltd

Also Published As

Publication number Publication date
CS735979A2 (en) 1984-02-13
ATA701479A (de) 1985-07-15
NO154522C (no) 1986-10-08
HU183087B (en) 1984-04-28
NO793469L (no) 1980-05-02
SU1014476A3 (ru) 1983-04-23
US4419352A (en) 1983-12-06
MA18631A1 (fr) 1980-07-01
CH643264A5 (fr) 1984-05-30
PH15442A (en) 1983-01-18
AT379811B (de) 1986-03-10
NZ191956A (en) 1984-05-31
DD146954A5 (de) 1981-03-11
IE49464B1 (en) 1985-10-16
PT70392A (en) 1979-11-01
DE2943658A1 (de) 1980-05-14
CA1142520A (fr) 1983-03-08
SG40885G (en) 1986-05-02
NL7907916A (nl) 1980-05-02
BR7907006A (pt) 1980-07-15
FI67702C (fi) 1985-05-10
KE3540A (en) 1985-07-12
MY8500439A (en) 1985-12-31
FI793369A (fi) 1980-05-01
GR73861B (fr) 1984-05-08
AU5228779A (en) 1980-05-08
FI67702B (fi) 1985-01-31
CU21123A (es) 1982-08-28
PL130691B1 (en) 1984-08-31
AU528648B2 (en) 1983-05-05
SE451071B (sv) 1987-08-31
NO154522B (no) 1986-06-30
LU81841A1 (fr) 1980-05-07
PL219304A1 (fr) 1980-12-01
DE2943658C2 (fr) 1991-08-01
IL58579A0 (en) 1980-01-31
CS231166B2 (en) 1984-10-15
HK66185A (en) 1985-09-13
SE7908995L (sv) 1980-05-01
FR2440371B1 (fr) 1983-01-28
DK458679A (da) 1980-05-01
IE792074L (en) 1980-04-30
AR230449A1 (es) 1984-04-30
IL58579A (en) 1985-12-31

Similar Documents

Publication Publication Date Title
FR2440371A1 (fr) Nouveaux composes azotes heterocycliques, des compositions pharmaceutiques en contenant et des procedes pour les preparer
FR2453148A1 (fr) Nouveaux derives arylsulfinyle d'acide acetohydroxamique, leur procede de preparation et leur application en therapeutique
FR2442054A1 (fr) Proteines purifiees, notamment interferon, procede de preparation et compositions pharmaceutiques les contenant
FR2427329A1 (fr) Nouveaux derives d'acides phenoxyalkylcarboxyliques et leur application en therapeutique, notamment en tant qu'agents hypolipidemiants et hypocholesterolemiants
FR2562539B1 (fr) Nouveaux derives de l'acide vinyl-4 benzoique, leur procede de preparation et leurs applications en therapeutique et comme ligands
FR2415112A1 (fr) Nouveaux derives spirothienohydantoines et composition pharmaceutique les contenant
FR2421889A1 (fr) Nouveaux derives d'acide thiazolidinecarboxylique-4 utiles comme medicaments antihypertenseurs et procedes pour leur preparation
FR2397403A1 (fr) Nouveaux derives de 1-acyl 2-cyano-aziridine, procede pour leur preparation et compositions pharmaceutiques contenant ces composes
TNSN98127A1 (fr) Derives d'azetidinylpropylpiperidine , procede pour leur preparation et compositions pharmaceutiques les contenant.
TNSN99013A1 (fr) Derives d'acide dihydroxyhexanoique nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2441627A1 (fr) Nouvelles spiro-polycyclo-imidazolidinediones et composition pharmaceutique les contenant
HUP9802121A2 (hu) Imidazolinszármazékok, eljárás előállításukra és e vegyületeket tartalmazó gyógyszerkészítmények
FR2448535A1 (fr) Nouveaux derives tricycliques et leurs sels, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant
TNSN98185A1 (fr) Derives d'isoquinoleine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
ATE31300T1 (de) Imidazol-2-yl-mercaptoalkansaeuren, verfahren zu deren herstellung und pharmazeutische formulierungen welche diese enthalten.
PT78275A (fr) Procede de preparation de nouveaux acides flavone-carboxyliques-4' et de compositions pharmaceutiques les contenant
FR2446829A1 (fr) Derives de polymethylene disubstitues en alpha, omega, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2448541A1 (fr) Nouveaux derives de l'oxoimidazoquinoxaline et leurs sels, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant
HUT35958A (en) Process for the production of pharmaceutical preparation suitable for therapic treatment of rheumatic diseases
BE878020A (fr) Derives n-substitues de l'acide aziridine-2-carboxylique immunostimulateurs, procedes de preparation et compositions pharmaceutiques les contenant
FR2416013A1 (fr) Derives d'acide (-)-(cis)-1,2-epoxypropylphosphonique, leur preparation et compositions pharmaceutiques les contenant
FR2446831A1 (fr) Derive oxyimino-e-homo-eburnane, procede pour le preparer et son utilisation dans une composition pharmaceutique pour la preparation de derives ester de l'acide apovincaminique
BE902055A (fr) Preparations pharmaceutiques.
PT78776B (fr) Procede de preparation de derives de l'acide bicyclo(3.2.1.)carboxylique et de compositions pharmaceutiques les contenant
FR2456744A1 (fr) Derives de la pyrazolo (1,5-c)quinazoline, procede de preparation de ces derives et medicaments contenant ces derniers

Legal Events

Date Code Title Description
ST Notification of lapse